Flinton Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$18.8M Sell
552,642
-108,810
-16% -$3.96M 0.58% 31
2019
Q2
$27.2M Sell
661,452
-60,884
-8% -$2.42M 0.86% 24
2019
Q1
$29.1M Buy
722,336
+54,863
+8% +$2.2M 0.96% 24
2018
Q4
$27.6M Buy
667,473
+67,524
+11% +$2.8M 1.05% 22
2018
Q3
$25.1M Buy
599,949
+48,842
+9% +$1.88M 0.78% 33
2018
Q2
$19M Buy
551,107
+23,108
+4% +$790K 0.61% 36
2018
Q1
$17.8M Buy
527,999
+60,234
+13% +$2.07M 0.6% 41
2017
Q4
$16.1M Buy
467,765
+88,477
+23% +$3.02M 0.55% 43
2017
Q3
$12.8M Buy
379,288
+62,506
+20% +$2.01M 0.46% 52
2017
Q2
$10.1M Buy
316,782
+69,058
+28% +$2.18M 0.37% 65
2017
Q1
$8.04M Buy
247,724
+73,101
+42% +$2.3M 0.31% 67
2016
Q4
$5.38M Buy
+174,623
New +$5.33M 0.24% 83

Other funds holding PFE

Flinton Capital Management's PFE Position: Q3 2019 in Review

Flinton Capital Management reduced its Pfizer (PFE) stake by 16% in Q3 2019, selling an estimated $3.96M and leaving 552,642 shares worth $18.8M. The position accounts for 0.58% of the portfolio, ranked #31.

Flinton Capital Management first reported a position in PFE in Q4 2016 and has held it in 12 quarters since. The position peaked at $29.1M in Q1 2019. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Flinton Capital Management held 552,642 shares of Pfizer worth $18.8M as of Q3 2019.
  • Flinton Capital Management sold 108,810 Pfizer shares in Q3 2019, an estimated $3.96M.
  • Pfizer made up 0.58% of Flinton Capital Management's portfolio in Q3 2019, its #31 holding.
  • Flinton Capital Management first reported a position in Pfizer in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Pfizer position peaked at $29.1M in Q1 2019.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.